# Director, Compensation at Olema

- Company: Olema
- What the company does: Olema Oncology is a clinical-stage biopharmaceutical company developing novel therapies to transform treatment for metastatic breast cancer and beyond. Backed by Lightspeed.
- Company website: https://olema.com/
- Type: Startups
- Level: Principal and up
- Location: Boston, Massachusetts
- Work setup: On-site
- Pay: $230K to $250K base salary per year (USD)
- Posted: 2026-08-28
- Apply by: 2026-10-12
- Apply: https://job-boards.greenhouse.io/olema/jobs/6173342004
- Page: https://www.1752.vc/careers/jobs/olema-director-compensation-2/

## About the role

Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in Q1 2027 which, if positive, could lead to our first potential approval and commercial launch in 2028.

## What they're looking for

- Bachelor’s degree in business, finance, accounting, economics, or a related field required, MBA or CPA preferred
- At least 10 years of progressive compensation experience, including significant hands-on experience within biotechnology, pharmaceuticals, or life sciences
- Progressive compensation experience, including compensation consulting organizations, highly preferred
- Demonstrated experience leading compensation strategy and programs within both small/high-growth and/or larger, more complex organizations
- Deep expertise in broad-based compensation for employees at the Vice President level and below, including base pay, annual incentives, equity, new-hire offers, promotions, retention awards, and off-cycle adjustments
- Proven experience designing and maintaining job architecture, career frameworks, job-evaluation and leveling methodologies, salary structures, range spreads, midpoint progressions, and range-placement guidelines

Tags: Business and Operations